ABUS
Arbutus Biopharma Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.26
-0.06 ▼ -1.39%
🌙 3월 13일 6:24 PM ET (한국 3/14 07:24)
$4.29
+0.03 ▲ +0.79%
| Index | RUT | P/E | - | EPS (ttm) | -0.22 | Insider Own | 21.88% | Shs Outstand | 0.19B | Perf Week | -5.96% |
| Market Cap | 0.82B | Forward P/E | - | EPS next Y | 14.78% | Insider Trans | - | Shs Float | 0.15B | Perf Month | 2.4% |
| Enterprise Value | 0.73B | PEG | - | EPS next Q | -0.04 | Inst Own | 63.59% | Short Float | 9.82% | Perf Quarter | -7.19% |
| Income | -0.04B | P/S | 56.08 | EPS this Y | 50.59% | Inst Trans | 1.2% | Short Ratio | 7.06 | Perf Half Y | -13.06% |
| Sales | 0.01B | P/B | 10.56 | EPS next 5Y | - | ROA | -35.5% | Short Interest | 14.76M | Perf YTD | -11.43% |
| Book/sh | 0.4 | P/C | 8.74 | EPS past 3/5Y | 23.21% 33.46% | ROE | -45.88% | 52W High | -16.47% ($5.10) | Perf Year | 28.31% |
| Cash/sh | 0.49 | P/FCF | - | Sales past 3/5Y | -17.5% 0.53% | ROIC | -51.89% | 52W Low | 57.49% ($2.70) | Perf 3Y | 43.92% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 47.93% | Gross Margin | 95.31% | Volatility(W/M) | 6.65% 5.98% | Perf 5Y | 12.4% |
| Dividend TTM | - | EV/Sales | 49.98 | Sales Y/Y TTM | 116.64% | Oper. Margin | -214.67% | ATR (14) | 0.27 | Perf 10Y | 10.65% |
| Dividend Ex-Date | - | Quick Ratio | 18.8 | EPS Q/Q | 61.27% | Profit Margin | -289.45% | RSI (14) | 43.09 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 18.8 | Sales Q/Q | -60.49% | SMA20 | -4.98% ($4.48) | Beta | 0.76 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 11000000 | SMA50 | -2.81% ($4.38) | Rel Volume | 0.72 | Prev Close | $4.32 |
| Employees | 44 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | -33.33% -58.24% | SMA200 | 4.46% ($4.08) | Avg Volume(3M) | 2.09M | Price | $4.26 |
| IPO | 2007/7/23 | Option/Short | Yes/Yes | Trades | 6600 | Volume | 1,496,660 | Change | -1.39% |
뉴스 로딩 중...